Clinical Trials Browser

Phase 1/2 × Advanced Intrahepatic Cholangiocarcinoma × sintilimab × Clear all

NCT06956716 2025-05-04

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

Phase 1/2 Recruiting

Gastrointestinal

Advanced Intrahepatic Cholangiocarcinoma